Citi maintains a 'Buy' rating on Medical Technology Stocks BAX, COV and MDT, but lowers price targets.

Citi analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE